MICHELLE TRICHE: Open Payments
NPI 1164884789 · SHERMAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$398 in 15 payments from 9 companies in 2025. Trend: 2023 $164 · 2024 $200 · 2025 $398
Food & beverage: $299Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $132 |
| ABBVIE INC. | 4 | $106 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: VRAYLAR, Auvelity, Veozah, GATTEX, CAPLYTA, MOUNJARO, TRUMENBA, Jornay PM.
Industry payments across TX — which companies pay providers there.
